Status:
WITHDRAWN
Strata EXPress™: A Study Using StrataEXP™ to Identify RNA-Expression Biomarkers in Advanced Cancer Patients
Lead Sponsor:
Strata Oncology
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The primary goal of this study is to identify patients with RNA expression profiles consistent with eligibility requirements for therapeutic clinical trials across solid tumors. Left-over tumor tissue...
Detailed Description
The primary goal of this study is to identify patients with RNA expression profiles consistent with eligibility requirements for therapeutic clinical trials across solid tumors. Left-over tumor tissue...
Eligibility Criteria
Inclusion
- Must be ≥18 years of age,
- Participant must have pathologically confirmed advanced, metastatic, or recurrent solid tumor,
- Measurable disease,
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2,
- Participant must meet at least 1 of the following:
- Is/has not adequately responded to standard therapy, or
- For whom no life-extending standard therapy exists, or
- Who decline standard therapy, or
- In the opinion of the investigator, is not a candidate for or would be unlikely to tolerate or derive significant clinical benefit from standard therapy
- Adequate cardiac, bone marrow, organ function \& laboratory parameters as determined by the treating physician for potential participation in a clinical trial,
- Leftover formalin-fixed, paraffin-embedded (FFPE) tumor tissue available for StrataEXP testing
Exclusion
- Females who are pregnant or nursing,
- History of stroke including transient ischemic attack (TIA) or acute myocardial infarction within 4 months of enrollment,
- Any other clinically significant medical condition that, in the opinion of the treating physician, makes participation in a clinical trial undesirable, including but not limited to ongoing or active infection, significant uncontrolled hypertension, or severe psychiatric illness.
Key Trial Info
Start Date :
February 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 22 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05312307
Start Date
February 6 2023
End Date
February 22 2024
Last Update
February 26 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.